Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.
about
Decreased expression of receptor tyrosine kinase of EphB1 protein in renal cell carcinomas.PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer.Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K.Eph receptors and ephrins: therapeutic opportunities.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer.EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.Molecular and functional crosstalk between extracellular Hsp90 and ephrin A1 signaling.Dysregulation of EGFR Pathway in EphA2 Cell Subpopulation Significantly Associates with Poor Prognosis in Colorectal Cancer.Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer.
P2860
Q34029227-1A79D5EE-C7FB-43C5-971A-FF7E758E2D15Q35691011-58B0DD45-A016-44FA-B50A-D172E76905D7Q37015731-AEF5E8D3-70CE-42C1-9A89-18476DACB22AQ38257853-4FAD6743-F68A-481A-9566-C7123AAE7017Q38258014-A641DA33-5EC5-47FB-BF18-DC0D8AF63D46Q38745843-F0C7D636-40EF-4AB5-82FD-A11E4B0CFD51Q38795257-34802046-EF9F-4B2A-8CDF-51D68AF0A25EQ47143187-B526D64C-1352-40D4-8737-0DC251F316DEQ50232638-6D10D07D-D048-4E05-85A4-689AD0B52C2AQ52751765-7D887733-34DF-47A8-B531-931563E56B6D
P2860
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.
@en
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.
@nl
type
label
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.
@en
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.
@nl
prefLabel
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.
@en
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.
@nl
P2093
P2860
P1476
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.
@en
P2093
Anil K Sood
Behrouz Zand
Bryan Fellman
Chad V Pecot
Chunhua Lu
Diana Urbauer
Duangmani Thanapprapasr
Heather J Dalton
Hee Dong Han
P2860
P304
P356
10.1158/1078-0432.CCR-13-2141
P407
P577
2014-01-31T00:00:00Z